Efficacy of leflunomide in the treatment of vasculitis

Only a few small case series, case reports, and one small clinical trial suggested some benefit of leflunomide (LEF) in anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitis and other vasculitides. We analysed the clinical efficacy and tolerability of LEF in a large cohort of patients with various vasculitides.This was a retrospective analysis of patients who received LEF for treatment of their vasculitis enrolled in the Vasculitis...